AI Summary

UC Irvine researchers are developing a new chemotherapy approach that adds a safety lock to a highly potent cancer drug. The lock prevents the drug from harming healthy tissue until it reaches cancer cells that contain high levels of a specific protein‑destroying activity. When the drug enters those cells, the lock is removed, allowing the drug to act only on the tumor. This strategy aims to reduce collateral damage while maintaining the drug’s effectiveness against cancer.

AI summaries can be wrong sometimes—always verify important details using the source article.